Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$275.23-3.20 (-1.15%)
Delayed quote: Sep 4, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 4, 2026, 4:00 PM EDT
Basis: latest reported fiscal year. Source: stored company filings; unavailable inputs remain N/A.
The latest annual annual revenue is $94.19B with a annual period change of +6.05%. Annual revenue is the total sales generated during the company's fiscal year.
Annual fiscal-year revenue; no daily interpolation.
| Date | Annual Revenue | % Change |
|---|---|---|
| 2025 | $94.19B | +6.05% |
| 2024 | $88.82B | +4.30% |
| 2023 | $85.16B | +6.46% |
| 2023 | $79.99B | +1.59% |
| 2022 | $78.74B | (4.65%) |
| 2021 | $82.58B | +0.64% |
| 2019 | $82.06B | +0.59% |
| 2018 | $81.58B | +6.71% |
| 2017 | $76.45B | +6.34% |
| 2016 | $71.89B | +2.59% |
| 2015 | $70.07B | (5.73%) |
| 2014 | $74.33B | +4.23% |
| 2013 | $71.31B | +6.08% |
| 2012 | $67.22B | +3.37% |
| 2011 | $65.03B | +5.59% |
| 2010 | $61.59B | (0.50%) |
| 2009 | $61.90B | (2.90%) |
| 2008 | $63.75B | +4.34% |
| 2007 | $61.09B | +14.57% |
| 2006 | $53.32B | +5.56% |
| 2005 | $50.51B | +6.69% |
| 2004 | $47.35B | +13.10% |
| 2003 | $41.86B | +15.33% |
| 2002 | $36.30B | +12.32% |
| 2001 | $32.32B | +10.78% |
| 2000 | $29.17B | +4.16% |
| 1999 | $28.01B | +16.72% |
| 1998 | $24.00B | +6.04% |
| 1997 | $22.63B | +4.67% |
| 1996 | $21.62B | N/A |